Latest
Osteonecrosis of the Jaw (ONJ)
& Related Newswire
6/19/2006 5:07:00 AM | Fosamax risk weighed 
=(0) This article is about a Massachusetts woman's decision to stop taking Fosamax after being informed of the risk of osteonecrosis of the jaw by her dental surgeon. The woman's dental work was elective, and another way to accomplish it was found, but in many cases extractions or other oral surgery is necessary even for patients on osteoporosis me...
Read More
6/16/2006 1:13:00 AM | State court to handle roughly 60 Novartis suits =(0) More than 60 pending lawsuits against drugmaker Novartis have been moved to a US District Court in Tennessee. The suits claim that the drugs Aredia and Zometa, both made by Novartis, caused them to suffer "jaw death" or osteonecrosis of the jaw. The plaintiffs claim that Novartis did not sufficiently warn doctors about this possibility. The en...
Read More
6/13/2006 10:14:00 PM | Breast Cancer, Osteoporosis And Bone Cancer Treatment Drugs May ... =(0) Patients and doctors need to be aware of the risks of biphosphonate drugs such as Fosamax. These drugs are widely prescribed for osteoporosis and some cancers because they slow down the process of bone cell removal and allow bone cells to last longer. However when the patient undergoes some dental procedures such as tooth extractions or other ...
Read More
4/19/2006 2:42:00 PM | Merck in court over osteoporosis drug =(0) The drug maker Merck has yet another lawsuit to contend with, this time over its osteoporosis medication Fosamax. A class of patients in Florida alleges that they developed osteonecrosis of the jaw, a rare but painful and debilitating condition, as a result of Fosamax treatment and that Merck was negligent in disclosing the risk. Merck cl...
Read More
4/13/2006 6:38:00 AM | Merck under fire again as US lawsuit targets Fosamax =(0) New concerns arise over the class of osteoporosis medication known as biphosphonates. Merck, the maker of one of these drugs, Fosamax, is being sued for negligence in the promotion of this drug by not disclosing an alleged side effect, osteonecrosis of the jaw. This is a rare but painful condition in which the jawbone disintegrates, requiring ...
Read More
3/22/2006 4:56:00 PM | New Data Show Zometa Increased Bone Mineral Density in Breast =(0) Postmenopausal women with certain types of breast cancer are treated in the long term with the drug Femara to reduce the risk of recurrence; however this treatment carries with it a risk of bone loss. Studies underway suggest that women given injections of Zometa from the onset of their cancer therapy have increased bone mineral density compared wi...
Read More
3/17/2006 12:52:00 PM | New Study Shows Women With Osteoporosis Preferred Once-Monthly ... =(0) This article concerns a study comparing two postmenopausal-osteoporosis medications, Boniva and Fosamax. It showed that a larger percentage of women would tend to stay on treatment and thus retain some protection against bone fracture when taking only one pill a month (Boniva) than one pill a week (Fosamax). Boniva belongs to the class of drugs kn...
Read More
2/27/2006 1:30:00 PM | Study Describes Osteonecrosis of the Jaw in Patients with Multiple ... =(0) Multiple myeloma, a type of blood cancer, has been associated with osteonecrosis of the jaw (ONJ), a painful condition involving the breakdown of bone. Risk of ONJ increases with recent history of dental extraction, and may also be related to treamtment with biphosphonates, drugs used to combat multiple myeloma. Zometa and Aredia are two such drugs...
Read More